3173 results for «3470»
3173 results
Achieving the optimal outcome using the latest self-expandable TAVI - LIVE case
17 Feb 2024 – From PCR Tokyo Valves 2024
An 86-year-old woman presented severe symptomatic aortic stenosis and coronary artery disease with a preserved LV function. The operators performed a PCI of the RCA ostium one month ago. The CT showed a small femoral access (diameter: 5.3 to 4.9 mm).
After a predilatation with a 20 mm...
Contemporary techniques for TAV-in-SAV interventions
18 Feb 2024 – From PCR Tokyo Valves 2024
Thanks to this session, take a look at the current outcomes of TAV-in-SAV, analyse the different types of valves and their fracturability, find out more, through case studies, about two different TAV-in-SAV techniques, with or without a stent, and learn how to avoid patient prosthesis mismatch...
Primary mitral regurgitation edge to edge repair with one device - LIVE case
18 Feb 2024 – From PCR Tokyo Valves 2024
An 83-year-old male presented symptomatic severe PMR due to lateral P2 chordal rupture, small LA and preserved LV function (68%). Watch the operators implant one XTW clip successfully.
LIVE case from Sendai Kousei Hospital - Sendai, Japan
Navigate the video by moving your mouse over the chapter icon in...
Shaping the future of structural heart disease intervention
18 Feb 2024 – From PCR Tokyo Valves 2024
Consult this session if you want to discuss the remaining challenges of transcatheter valvular interventions, and to review latest innovations for structural heart disease.
Late-Breaking Trial session
17 Feb 2024 – From PCR Tokyo Valves 2024
Explore pivotal findings from registries and studies, including the OCEAN-TAVI Registry on PPM prevalence in Asian TAVR patients, SIL-TAVI Registry insights on TAVI outcomes in cancer patients, the EXPAND G4 study's outcomes for Japanese MitraClip G4 recipients, and TRISTAR study's 30-day results on K-Clip for tricuspid...
State-of-the-art on left main interventions in Latin America
16 May 2024 – From EuroPCR 2024
This session, in collaboration with the Sociedad Latino Americana de Cardiologia Intervencionista (SOLACI), provides insights into the management of left main coronary artery disease in Latin America. Attendees will learn about the revascularization guidelines for left main in the region, the approaches to left main bifurcations...
The landscape of structural heart interventions
16 May 2024 – From EuroPCR 2024
This session provides a comprehensive overview of the management of structural heart disease, focusing on the differences in procedural approaches for aortic and mitral interventions. Attendees will learn effective strategies to manage procedural complications, as well as how to adapt patient pathways for various structural heart...
Endovascular management for aortic arch aneurysm
16 May 2024 – From EuroPCR 2024
This session showcases a series of complex clinical cases highlighting the endovascular management of aortic arch aneurysms. Attendees will witness scenarios involving hybrid aortic arch debranching with thoracic endovascular aortic repair, the use of fenestrated aortic arch stent grafts, techniques for left subclavian artery preservation, and...
TAVI: how to deal with aortic regurgitation
16 May 2024 – From EuroPCR 2024
This session will explore various cases of TAVI for the management of aortic regurgitation, including patients with pure aortic regurgitation, large annuli, low coronary height, and left ventricular assist devices. Discussions will focus on the transcatheter approach, device selection, and techniques to address these challenging scenarios.
TAVI: managing acute procedural complications
16 May 2024 – From EuroPCR 2024
From deep implantation challenges to embolization and iatrogenic dissections, each presentation highlights techniques for addressing critical procedural hurdles. Topics include bailout strategies, managing embolized valves, complex second valve placements, and handling unusual TAVR scenarios, offering insights on navigating complications and ensuring procedural safety.
Valvular and structural interventions
16 May 2024 – From EuroPCR 2024
This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...
Tackling challenging scenarios of left main PCI
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the South African Society of Cardiovascular Intervention (SASCI), Bangladesh Society of Cardiovascular Intervention and Indonesian Society of Interventional Cardiology, focuses on overcoming the most challenging issues in complex left main bifurcation stenosis PCI. It includes case discussions on techniques to...
Innovations in transcatheter valve interventions: moving the flow in the right direction
13 May 2024 – From EuroPCR 2024
PCR's Got Talent - Round 2 - Session 1
15 May 2024 – From EuroPCR 2024
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
TEER for primary mitral regurgitation - LIVE case
15 May 2024 – From EuroPCR 2024
A 76-year-old male, with previous CABG in 2015, hypertension, diabetes, and pulmonary hypertension (WHO2), presented with severe symptomatic primary MR (P3 flail).
The operators implanted 1 MitraClip (XTW) step-by-step, from the transseptal puncture to the closure, guided by TEE echo and under general anaesthesia, via the venous...
Nightmare cases
15 May 2024 – From EuroPCR 2024
PCR's Got Talent - Round 2 - Session 2
15 May 2024 – From EuroPCR 2024
This session features a selected abstract submission from EuroPCR 2024 on plaque characterization, outcomes, and predictors of recurrent events in stent failure, as studied using optical coherence tomography (OCT).
Antiplatelet de-escalation after complex PCI: when and how?
15 May 2024 – From EuroPCR 2024
The ARC consensus on DCB - evidence-based DCB technology
15 May 2024 – From EuroPCR 2024
In this replay, discover why DCBs are essential in treating de novo CAD, the importance of optimal lesion preparation for long-term success, and how future trials will focus on treatment strategies rather than device comparisons, highlighting the need for further research.
